Highlights Renovaro Inc.

Equities

RENB

US29350E1047

Market Closed - Nasdaq Other stock markets 01:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
1.58 ^USD	+1.94%		+5.33%	-50.16%

Jul. 01	Renovaro Inc.(NasdaqCM:RENB) added to Russell Small Cap Comp Value Index	CI
Jul. 01	Renovaro Inc.(NasdaqCM:RENB) added to Russell Small Cap Completeness Index	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Renovaro Says Investors Commit $10 Million Additional Equity	Jun. 14	MT
Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy	May. 24	MT
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	May. 24	CI
Renovaro Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 15	CI
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	Apr. 24	MT
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14	CI
Renovaro's GEDi Cube Agrees to Acquire 75% Stake in Cyclomics	Feb. 13	MT
Renovaro Shares Tumble Following Report From Short-Seller Hindenburg	Feb. 13	MT
Renovaro Biosciences Inc. completed the acquisition of GEDi Cube Intl Ltd. for $59.2 million.	Feb. 12	CI
Renovaro Biosciences' Shareholders Approve Share Issuance for Merger Deal With GEDi Cube	Jan. 25	MT
Renovaro Biosciences Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14	CI
Renovaro Biosciences Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-02	CI
Renovaro Biosciences, GEDi Cube Enter Stock-for-stock Acquisition Deal	23-09-29	MT
Renovaro BioSciences Signs Letter of Intent to Merge With GEDi Cube; Shares Rise	23-08-09	MT
Renovaro Biosciences Inc. signed a letter-of-intent to acquire GEDi Cube Intl Ltd.	23-08-08	CI
Enochian Biosciences Inc. Announces That Its Cancer Platform Remains on Track for Trials in Humans Following FDA Review	23-06-08	CI
Enochian Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-12	CI
Enochian Biosciences Inc. Announces Scientific Presentation of Proof-of-Concept Studies for Potential Therapy for Cancers with a Poor Life Expectancy	23-03-29	CI
Enochian Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-03-09	CI
Enochian Biosciences Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	23-03-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Renovaro Inc.

Equities

RENB

US29350E1047

Highlights

Filters